*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C222 - Hepatoblastoma - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 21.15 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 11,287 |
| Total Hospitalizations with ICD C222 - Hepatoblastoma | 13 |
| DRG Share of Total Hospitalizations | 0.03 |
| % of Total ICD C222 - Hepatoblastoma in DRG | 23.64 |
| Avg LOS at DRG | 8.09 |
| Avg LOS with ICD C222 - Hepatoblastoma | 3.15 |
| Readmission Rate at DRG | 63.47 |
| Readmission Rate with ICD C222 - Hepatoblastoma | NA |
| Unplanned Readmission Rate at DRG | 16.01 |
| Unplanned Readmission Rate with ICD C222 - Hepatoblastoma | NA |
| Total Medicare payments at DRG | $252,996,223 |
| Total Medicare payments with ICD C222 - Hepatoblastoma | $194,240 |
| Total Medicare payment per Day at DRG | $2,772 |
| Total Medicare payment per Day with ICD C222 - Hepatoblastoma | $4,738 |
| Total Medicare payment per Hospitalization at DRG | $22,415 |
| Total Medicare payment per Hospitalization with ICD C222 - Hepatoblastoma | $14,942 |
| Total Medicare Charges at DRG | $1,139,315,524 |
| Total Medicare Charges with ICD C222 - Hepatoblastoma | $332,673 |
| Avg Charges at DRG | $100,941 |
| Avg Charges with ICD C222 - Hepatoblastoma | $25,590 |
| Mortality Rate at DRG | 3.42 |
| Mortality Rate with ICD C222 - Hepatoblastoma | NA |
| SNF Discharge Rate at DRG | 9.94 |
| SNF Discharge Rate with ICD C222 - Hepatoblastoma | NA |
| Home Discharge Rate at DRG | 62.95 |
| Home Discharge Rate with ICD C222 - Hepatoblastoma | 92.31 |